Skip to main content

S. 2909

Referred to Committee

Assessing Barriers to Opioid Use Disorder Treatment Act

Introduced 5/22/2018•115th Congress•Senate

Latest Action

Read twice and referred to the Committee on Finance.

5/22/2018 • Senate

Summary

Assessing Barriers to Opioid Use Disorder Treatment Act

This bill requires the Government Accountability Office to report on barriers to the provision of medication used to treat substance use disorders (e.g., buprenorphine) under Medicaid distribution models (e.g., provider purchasing, storage, and administration of medications).

Introduced in Senate • 5/22/2018

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Congressional oversightDrug therapyDrug trafficking and controlled substancesDrug, alcohol, tobacco useGovernment studies and investigationsMedicaidPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (3)

Party Breakdown

2
Democrats
1
Republicans
0
Independents

Sponsor

S[
Sen. Heller, Dean [R-NV]

Republican • NV

Sponsored 5/22/2018

Cosponsors (2)

S[
Sen. Bennet, Michael F. [D-CO]

D-CO

Joined 5/22/2018

S[
Sen. Manchin, Joe, III [D-WV]

D-WV

Joined 9/12/2018

Bill Journey

Originated in the Senate

Introduced

May 22, 2018

Read twice and referred to the Committee on Finance.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate5/22/2018

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors2